Register
Login:
Share:
Email Facebook Twitter

Caps Lock on… DAVID LENIGAS on this week’s Share Views!! Watch here

Share Views Episode 10 - DAVID LENIGAS talks Gatwick Gusher and AAAP


Verona Pharma Share Price (VRP)



Share Price Information for Verona Pharma (VRP)


Share Price: 3.20Bid: 3.10Ask: 3.30Change: -0.20 (-5.88%)Faller - Verona Pharma
Spread: 0.20Spread as %: 6.45%Open: 3.40High: 3.40Low: 3.125Yesterday’s Close: 3.40

Verona Pharma Plc Ord 0.1P

Verona Pharma is listed in the FTSE AIM All-Share
Verona Pharma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
3.20

Share Price SpacerBid
3.10

Share Price SpacerAsk
3.30

Share Price SpacerChange
-5.88%-0.20

Share Price SpacerVolume
985,835

Share Price SpacerOpen
3.40

Share Price SpacerHigh
3.40

Share Price SpacerLow
3.125

Share Price SpacerClose
3.40

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 2,565.72m £82.10m 50,000

52 Week High 5.13 52 Week High Date 15-MAR-2016
52 Week Low 2.20 52 Week Low Date 19-JAN-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
24 441,645 544,190 -4.384 -0.73 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

29-Sep-16
14:47:47
3.27
75,000
Buy* 
3.10
3.30
2,453
Trade Type:
Ordinary

29-Sep-16
14:33:06
3.27
55,000
Buy* 
3.10
3.30
1,799
Trade Type:
Ordinary

29-Sep-16
14:18:43
3.12
34,209
Sell* 
3.10
3.30
1,067
Trade Type:
Ordinary




View more Verona Pharma trades >>

Directors Deals for Verona Pharma (VRP)
Trade DateActionNotifierPriceCurrencyAmountHolding
09-Aug-16Buy
Trade Notifier Information for Verona Pharma
Sven Jan-Anders Karlsson held the position of CEO at Verona Pharma at the time of this trade.
 Sven Jan-Anders Karlsson
3.25GBX600,0003470000
20-Jan-16Buy
Trade Notifier Information for Verona Pharma
David Ebsworth held the position of Non-Executive Chairman at Verona Pharma at the time of this trade.
 David Ebsworth
2.5GBX400,0004599774
03-Dec-15Buy
Trade Notifier Information for Verona Pharma
David Ebsworth held the position of Non-Executive Chairman at Verona Pharma at the time of this trade.
 David Ebsworth
3.25GBX370,0004199774
View more Verona Pharma directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Today 13:34wudiMol, you are welcome3.125No Opinion
......don't forget there are other institutional shareholders who held under 3%(02Sep 16), put them together 13.51%
Today 10:43wudiTo mol42 on iii board3.225No Opinion
My record on 15April 2016
Fidelity held 76,394,918 back then, so its not new entrant but top up
Big jump is Vivo Capital from 82,000,000 to now 315,492,342 (no doubt 2.87 top up, or average down vrp had 5p placing few years ago I believe.)
Arthurian Life Sciences increase their holding as well
Aviva dropped a bit , however according to your record, it picked up again......
Anyway, fun time ahead.
Today 08:43wudiThat's the way to do it3.225No Opinion
smash sp down, so Mr. Morgan can hop in...
Wed 09:27wudiour savvy new CFO's purchase3.40No Opinion
RNS will be the next, but what price he will get?????
Mon 17:50bewiseVrp3.40Strong Buy
Good news today and Fri with the buy rating.....clock ticking to see if we get that Nasdaq listing, if successful a major move forward for vrp and us:)
Mon 14:25mc37RE: NASDAQ listing3.40No Opinion
Do we know if NASDAQ is happening?

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Verona Pharma (VRP) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.